SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-048699
Filing Date
2021-07-29
Accepted
2021-07-29 19:41:30
Documents
2
Period of Report
2021-07-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4365
2 POA DOCUMENT poa.txt EX-24.3_1001108 2023
  Complete submission text file 0001209191-21-048699.txt   7795
Mailing Address C/O BLUEBIRD BIO, INC. 60 BINNEY STREET CAMBRIDGE MA 02142
Business Address
Walsh Jeffrey T. (Reporting) CIK: 0001578251 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40656 | Film No.: 211129361

Mailing Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080 415-865-2066
Tenaya Therapeutics, Inc. (Issuer) CIK: 0001858848 (see all company filings)

IRS No.: 813789973 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences